Skip to content
healthcare.dev
Get a free key

TYENNE

NDC 65219-594, Tocilizumab-aazg, injection, solution, concentrate, from Fresenius Kabi USA, LLC.

Product NDC
65219-594
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761275
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-594 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOCILIZUMAB400 mg/20mL

Pharmacologic classes

Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]

Package NDCNDC-11Package
65219-594-20652190594201 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e400bbe6-43c5-4de6-82b9-cb44ce3cd906

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65219-594

Use it

Look up 65219-594 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-594 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-594. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.